IIPLA Newsroom

IIPLA News

Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.

News Archive

Latest IP news

Filtered news

News results

659 articles matching your filters, newest first.

American Fusion Expands Texatron Patent Portfolio to 151 Applications, Advances Testing Infrastructure and National Exchange Uplisting Plans
PatentsGlobal

American Fusion Expands Texatron Patent Portfolio to 151 Applications, Advances Testing Infrastructure and National Exchange Uplisting Plans

The fusion technology company files 21 new U.S. patent applications, secures terms for a dedicated test site, and evaluates uplisting to Texas Stock Exchange and other national ma…

American Fusion Inc. (OTCQB: AMFN) has filed 21 additional U.S. patent applications for its Texatron™ fusion platform, increasing its pending portfolio to 151. The company is progressing with testing at a university lab while negotiating acquisition terms for a dedicated testing facility. Concurrently, American Fusion…

Tuesday, September 22, 2026
IIPLA News Desk
Europe Patents Update Puts EU IP Valuation Plan and Spurs Patent Expertise Concerns Strateg…
PatentsGlobal

Europe Patents Update Puts EU IP Valuation Plan and Spurs Patent Expertise Concerns Strateg…

Practical patents context for IP teams tracking Patents, EU IP Valuation Plan, Spurs Patent Expertise Concerns.

IIPLA reviews the patents implications of Patents, EU IP Valuation Plan, Spurs Patent Expertise Concerns, with practical notes for Europe IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Monday, September 21, 2026
IIPLA News Desk
USA Patents Update Puts Join Us and Panel Discussion Strategy in Focus
PatentsGlobal

USA Patents Update Puts Join Us and Panel Discussion Strategy in Focus

Practical patents context for IP teams tracking Patents, Join Us, Panel Discussion.

IIPLA reviews the patents implications of Patents, Join Us, Panel Discussion, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Monday, September 21, 2026
IIPLA News Desk
Patents Update Puts Cops and Police Lines Strategy in Focus
PatentsGlobal

Patents Update Puts Cops and Police Lines Strategy in Focus

Practical patents context for IP teams tracking Patents, Cops, Police Lines.

IIPLA reviews the patents implications of Patents, Cops, Police Lines, with practical notes for global IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Monday, September 21, 2026
IIPLA News Desk
China Patents Update Puts Secures Hong Kong Patent and Lung Cancer Detection Technology Str…
PatentsGlobal

China Patents Update Puts Secures Hong Kong Patent and Lung Cancer Detection Technology Str…

Practical patents context for IP teams tracking Patents, Secures Hong Kong Patent, Lung Cancer Detection Technology.

IIPLA reviews the patents implications of Patents, Secures Hong Kong Patent, Lung Cancer Detection Technology, with practical notes for China IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Friday, September 18, 2026
IIPLA News Desk
USA Patents Update Puts Silo Pharma Receives U.S and Patent Allowance Strategy in Focus
PatentsGlobal

USA Patents Update Puts Silo Pharma Receives U.S and Patent Allowance Strategy in Focus

Practical patents context for IP teams tracking Patents, Silo Pharma Receives U.S, Patent Allowance.

IIPLA reviews the patents implications of Patents, Silo Pharma Receives U.S, Patent Allowance, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Friday, September 18, 2026
IIPLA News Desk
bioAffinity Technologies Secures Hong Kong Patent for CyPath® Lung Cancer Diagnostic, Bolstering Asian Market Entry
PatentsGlobal

bioAffinity Technologies Secures Hong Kong Patent for CyPath® Lung Cancer Diagnostic, Bolstering Asian Market Entry

The granted patent complements existing Chinese intellectual property, reinforcing bioAffinity’s position in Asia’s lung cancer diagnostic landscape

bioAffinity Technologies has obtained a Hong Kong patent for its CyPath® Lung diagnostic technology, enhancing its patent portfolio alongside a recent Chinese patent. This dual protection supports the company’s strategy to address the significant lung cancer burden in Asia with its noninvasive, flow cytometry-based di…

Thursday, September 17, 2026
IIPLA News Desk
Fabric.AI Engages Haynes and Boone to Safeguard Neural I/o™ IP in Collaboration with Kopin Corporation
PatentsGlobal

Fabric.AI Engages Haynes and Boone to Safeguard Neural I/o™ IP in Collaboration with Kopin Corporation

Haynes and Boone to lead patent strategy and licensing efforts for Fabric.AI’s MicroLED-based Neural I/o™ technology, targeting AI data center efficiency enhancements

Fabric.AI has appointed Haynes and Boone, LLP as its intellectual property counsel to support the development and protection of Neural I/o™, a joint MicroLED optical interconnect technology with Kopin Corporation. This collaboration aims to address bandwidth and energy efficiency challenges in next-generation AI data…

Thursday, September 17, 2026
IIPLA News Desk
EnergyPathways Gains Market Attention Following New UK Intellectual Property Patent Application Disclosure
PatentsUK

EnergyPathways Gains Market Attention Following New UK Intellectual Property Patent Application Disclosure

EnergyPathways’ recent update on its intellectual property patent application has sparked renewed interest among UK investors amid a busy London trading session.

EnergyPathways (LON:EPP) has entered the spotlight after issuing a regulatory disclosure concerning its intellectual property patent application. This development provides a fresh, date-stamped update that market participants are using to reassess the company’s position within the broader context of sector activity an…

Thursday, September 17, 2026
IIPLA News Desk
Fabric.AI Engages Haynes and Boone to Fortify Joint IP Portfolio with Kopin on Neural I/O Technology
PatentsGlobal

Fabric.AI Engages Haynes and Boone to Fortify Joint IP Portfolio with Kopin on Neural I/O Technology

Fabric.AI retains top-tier IP counsel Haynes and Boone to support patent strategy and licensing for collaborative MicroLED optical interconnect innovations with Kopin Corporation

Fabric.AI, a Nasdaq-listed AI infrastructure firm, has appointed Haynes and Boone, LLP as intellectual property counsel to advance and protect the Neural I/O™ technology it co-develops with Kopin Corporation. This strategic move aims to establish a robust patent portfolio amid ongoing technical discussions with major…

Thursday, September 17, 2026
IIPLA News Desk
Indonesia Commits to Active Participation in WIPO Talks on Cultural Heritage Protection
PatentsGlobal

Indonesia Commits to Active Participation in WIPO Talks on Cultural Heritage Protection

Culture Minister Fadli Zon emphasizes safeguarding traditional knowledge and equitable benefit-sharing at WIPO negotiations

Indonesia has declared its readiness to contribute its national experience in cultural documentation and preservation during the 53rd WIPO Intergovernmental Committee meeting. Culture Minister Fadli Zon highlighted the importance of protecting traditional knowledge and cultural expressions as integral to community ide…

Thursday, September 17, 2026
IIPLA News Desk
StickIt Technologies Advances Corporate Strategy with New CEO, Board Members, Debt Restructuring, and IP Portfolio Expansion
PatentsGlobal

StickIt Technologies Advances Corporate Strategy with New CEO, Board Members, Debt Restructuring, and IP Portfolio Expansion

The cannabinoid delivery technology firm announces leadership changes, financial recapitalization, and updates on its patent-protected therapeutic compound delivery systems.

StickIt Technologies Inc. has appointed Dr. Adi Zuloff-Shani as CEO and added two independent directors to its board, aiming to enhance governance and commercial growth. The company restructured approximately $617,000 in insider debt through a loan acquisition by Capitalink Ltd. and completed a non-brokered private pl…

Thursday, September 17, 2026
IIPLA News Desk
Saudi Arabia Advances Innovation Strategy with Emphasis on R&D and Intellectual Property Commercialization
PatentsMiddle East

Saudi Arabia Advances Innovation Strategy with Emphasis on R&D and Intellectual Property Commercialization

Al Tamimi & Company highlights Kingdom’s shift towards developing homegrown technologies and strengthening IP frameworks to drive economic diversification

Saudi Arabia is transitioning its innovation focus from manufacturing to creating and owning intellectual property, aiming to transform research and development into strategic economic assets. Ahmad Saleh of Al Tamimi & Company outlines how institutional reforms and policy frameworks are positioning the Kingdom to com…

Thursday, September 17, 2026
IIPLA News Desk
USA Patents Update Puts TCI Entertainment Aligns and Globant Strategy in Focus
PatentsGlobal

USA Patents Update Puts TCI Entertainment Aligns and Globant Strategy in Focus

Practical patents context for IP teams tracking Patents, TCI Entertainment Aligns, Globant.

IIPLA reviews the patents implications of Patents, TCI Entertainment Aligns, Globant, with practical notes for USA IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Wednesday, September 16, 2026
IIPLA News Desk
Europe Patents Update Puts Manitoba and Winnipeg Sun Research Manitoba Strategy in Focus
PatentsGlobal

Europe Patents Update Puts Manitoba and Winnipeg Sun Research Manitoba Strategy in Focus

Practical patents context for IP teams tracking Patents, Manitoba, Winnipeg Sun Research Manitoba.

IIPLA reviews the patents implications of Patents, Manitoba, Winnipeg Sun Research Manitoba, with practical notes for Europe IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Wednesday, September 16, 2026
IIPLA News Desk
China’s Supreme People’s Court Defines Profit-Based Criteria for Inventor Compensation in Biosimilar Patent Dispute
PatentsChina

China’s Supreme People’s Court Defines Profit-Based Criteria for Inventor Compensation in Biosimilar Patent Dispute

Landmark ruling clarifies statutory remuneration for service inventions, emphasizing annual operating profit over product lifecycle profitability

In a pivotal decision, China’s Supreme People’s Court resolved a dispute over inventor remuneration tied to a patented biosimilar adalimumab formulation. The court established that remuneration is owed based on annual operating profits generated by the patented invention’s commercial implementation, regardless of the…

Wednesday, September 16, 2026
IIPLA News Desk
Vietnamese Experts Stress Strategic IP Management to Commercialize Pharmaceutical Innovations
PatentsGlobal

Vietnamese Experts Stress Strategic IP Management to Commercialize Pharmaceutical Innovations

Bridging the gap between laboratory research and market success requires proactive intellectual property protection, valuation, and commercialization strategies in Vietnam’s pharm…

Pharmaceutical research in Vietnam faces challenges beyond invention creation, notably in transforming protected intellectual property into market-ready products. Experts from the Intellectual Property Office of Viet Nam and leading medical institutions emphasize the need for early IP identification, valuation, and st…

Wednesday, September 16, 2026
IIPLA News Desk
Page 2 of 37
Newsroom tools
Newsletters & Digests

Subscribe to IIPLA Newsroom

Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.